NCT03999983 Vertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER)
| NCT ID | NCT03999983 |
| Status | Recruiting |
| Phase | — |
| Sponsor | St. Louis University |
| Condition | Vertebral Artery Stenosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2019-11-19 |
| Primary Completion | 2026-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2019-11-19 with a primary completion date of 2026-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A retrospective and prospective registry of patients admitted for stroke and evidence of Vertebral Artery Origin Stenosis (VAOS).
Eligibility Criteria
Inclusion Criteria: 1. Patients between 18 and 90 years of age 2. Patient has experienced a posterior circulation ischemic event 3. Patient has angiographically confirmed bilateral vertebral artery origin disease (Hypoplasia, occlusion, or stenosis). 4. Patient has \>50% stenosis on the side being targeted for therapy Exclusion Criteria: 1. Pregnant women 2. Contrast Indication to the use of anti-platelet drugs 3. There is tandem vertebral or basilar artery stenosis 4. The serum creatinin is \>2.5 5. Baseline modified Rankin score is \>3 6. \< 5 years life expectancy
Contact & Investigator
Randall Edgell, MD
PRINCIPAL INVESTIGATOR
St. Louis University
Frequently Asked Questions
Who can join the NCT03999983 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Vertebral Artery Stenosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03999983 currently recruiting?
Yes, NCT03999983 is actively recruiting participants. Contact the research team at randall.edgell@health.slu.edu for enrollment information.
Where is the NCT03999983 trial being conducted?
This trial is being conducted at Jacksonville, United States, Tampa, United States, Winfield, United States, Iowa City, United States and 6 additional locations.
Who is sponsoring the NCT03999983 clinical trial?
NCT03999983 is sponsored by St. Louis University. The principal investigator is Randall Edgell, MD at St. Louis University. The trial plans to enroll 150 participants.